ESMO 2017: Industry Participation

ESMO 2017, the world's premier congress in medical oncology will be taking place in Madrid from the 8 - 12 September 2017.

The congress will attract an international community of experts, across disciplines and all focused on finding the most effective cancer treatment solutions available today.This is the ultimate goal of ESMO 2017 and we count on our Industry Partners active in oncology to help us again further our science and improve the lives of patients through continued education.

Fast Facts: ESMO 2016 Congress

  • 20 767 participants, 124 countries
  • 5 700 m² exhibition space, 111 exhibitors
  • 515 guest faculty
  • 194 sessions, 21 tracks 
  • 2 884 submitted abstracts

How can I participate in 2017?

At ESMO we are committed to providing our industry partners with a variety of solutions to facilitate your presence at our conference.Contact the  ESMO Events Sponsorship Team for more details and we look forward to hearing from you!

Who has already signed up?

We gratefully acknowledge the valuable contribution of the following organisations in the ESMO 2017 Congress through their presence in the exhibition hall, organisation of sponsored sessions, or via sponsorship activities (as of May 2017):

Companies
  • AbbVie, Inc.
  • Advanced Accelerator Applications International SA
  • Advanced Targeting Systems
  • Agendia N.V.
  • Agilent Technologies
  • Amgen (Europe) GmbH
  • ArcherDX
  • Astellas Pharma Europe Ltd.
  • AstraZeneca
  • Asuragen, Inc.
  • Axon Libreria, S.L.
  • B. Braun Melsungen AG
  • Bavarian Nordic
  • Baxter Healthcare SA
  • Bayer Healthcare Pharmaceuticals, Inc. 
  • Biocartis NV
  • Bioclinica
  • Biosimilar Medicines, a Medicines for Europe sector group
  • BMJ Publishing Group Ltd.
  • Boehringer Ingelheim 
  • Braster 
  • Bristol-Myers Squibb
  • Caris Life Sciences
  • Cascadian Therapeutics, Inc.
  • Catalysis S.L.
  • Celgene International
  • Celltrion Healthcare Co., Ltd.
  • Chiltern International Ltd.
  • Clinical Research Malaysia (CRM)
  • Clovis Oncology
  • Color Genomics
  • Cyagen Biosciences
  • Daiichi Sankyo Europe GmbH
  • Definiens AG
  • Delcath Systems Limited
  • Diatech Pharmacogenetics
  • Eisai Europe Limited
  • Elsevier B.V.
  • Europital
  • EUSA Pharma (UK) Ltd.
  • F.Hoffmann-La Roche 
  • Fresenius Kabi Deutschland GmbH
  • Genomic Health International Sarl
  • HalioDx 
  • Halozyme, Inc.
  • Helsinn Healthcare SA
  • Histalim
  • HTG Molecular Diagnostics
  • Imedex
  • Incyte Corporation
  • Ipsen
  • Janssen Pharmaceutica NV
  • Linical
  • Lunit
  • M3 Global Research
  • medac GmbH
  • Median Technologies
  • Medscape LLC
  • Merck / Pfizer Alliance
  • Merck KGaA
  • Molecular Health GmbH
  • MSD
  • Mylan
  • NanoString Technologies
  • National Comprehensive Cancer Network (NCCN) 
  • NeoGenomics
  • Nestle Health Science
  • Noona Healthcare Oy
  • Northwest Biotherapeutics Inc.
  • Novartis
  • Novella Clinical, a Quintiles company
  • Nutricia Advanced Medical Nutrition
  • OncoDNA s.a.
  • Oxford University Press
  • Paxman Coolers Ltd.
  • Peregrine Pharmaceuticals Inc.
  • Pfizer Oncology
  • PharmaMar, S.A.
  • Pharmanovia A/S
  • Physicians' Education Resource®, LLC
  • Pierre Fabre Medicament
  • Pivotal SL
  • prIME Oncology
  • QuintilesIMS
  • Samsung Bioepis Co., Ltd.
  • Sandoz International GmbH
  • Sanofi Genzyme
  • Seattle Genetics
  • Servier
  • Shire
  • Sirtex Medical Europe GmbH
  • Sophia Genetics SA
  • Sotio a.s.
  • Spandidos Publications
  • Springer Healthcare
  • Sysmex Inostics GmbH
  • Takeda Oncology
  • Tesaro
  • Teva Pharmaceuticals Europe BV
  • The JAMA Network
  • Thermo Fisher Scientific
  • Varian Medical Systems International AG
  • Wisepress Ltd.